Glimitos MV 1mg/500mg/0.3mg Tablet
Marketer
Atos Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimitos MV 1mg/500mg/0.3mg Tablet
DiaBeta-Comb 1mg/500mg/0.3mg tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta-Comb with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms like sweating, lightheadedness, headache, and tremors. Learn to identify and manage these symptoms; maintain regular meals and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any prior heart conditions before commencing treatment; it may be unsuitable. Pregnant or lactating individuals should consult their physician prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.
Primary Ingredients of Glimitos MV 1mg/500mg/0.3mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Glimitos MV 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glimitos MV 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Glimitos MV 1mg/500mg/0.3mg tablet on an empty stomach.
Common Side effects of Glimitos MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimitos MV 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimitos MV 1mg/500mg/0.3mg tablets on an empty stomach.
How Glimitos MV 1mg/500mg/0.3mg Tablet works:
Each Glimitos MV 1mg/500mg/0.3mg tablet contains a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glimitos MV 1mg/500mg/0.3mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimitos MV 1mg/500mg/0.3mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimitos MV 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving should these conditions arise.
KidneyUNSAFE
Glimitos MV 1mg/500mg/0.3mg Tablets pose a likely risk for individuals with kidney impairment and should be omitted. Seek medical advice before use. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimitos MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimitos MV 1mg/500mg/0.3mg Tablet :
Should you forget to take your Glimitos MV 1mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimitos MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently